Home / Companies / Burroughs Wellcome Co.

Burroughs Wellcome Co.

FDA Regulatory Profile

Summary

Total Recalls
0
510(k) Clearances
17
Inspections
0
Compliance Actions
0

Recent 510(k) Clearances

K-NumberDeviceDate
K820069WELLCOGEN GROUP BFebruary 18, 1982
K813508SAC-CELDecember 29, 1981
K810215DAC-CEL HCGApril 17, 1981
K810214DAC-CEL DIAGNATALMarch 6, 1981
K810212DAC-CEL T3 UPTAKEFebruary 10, 1981
K810213DAC-CEL TSHFebruary 10, 1981
K791232DAC-CEL T3September 4, 1979
K791231DAC-CEL T4September 4, 1979
K781607STREP-TEXOctober 17, 1978
K780873THYMUNE-MJune 14, 1978
K780874THYMUNE-TJune 14, 1978
K780475DAC-CEL DIGOXIN RADIOIMMUNOASSAY KITApril 24, 1978
K771560TOXHA TESTSeptember 15, 1977
K771583FLUORESCENT ANTI. ANTI-HUMAN C3September 2, 1977
K771562AGGLUTINATING SERUM W135August 25, 1977
K771139CRP-WELLCOTESTJuly 14, 1977
K770269CAMMADISK DIGOXINMarch 16, 1977